Retrovirus meeting. Novel attacks on HIV move closer to reality.
Jon
J
Cohen
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D019143:Evolution, Molecular; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D009930:Organic Chemicals / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011323:Primates; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D016097:Simian Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000235:genetics; D000068698:Tenofovir
D019380:Anti-HIV Agents; D009930:Organic Chemicals; D063065:Organophosphonates; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D000068698:Tenofovir; D000225:Adenine